Prevalence and characteristics of long COVID-19 in Jordan: A cross sectional survey

Early in the pandemic, the spread of the emerging virus SARS-CoV-2 was causing mild illness lasting less than two weeks for most people, with a small proportion of people developing serious illness or death. However, as the pandemic progressed, many people reported suffering from symptoms for weeks or months after their initial infection. Persistence of COVID-19 symptoms beyond one month, or what is known as long COVID-19, is recognized as a risk of acute infection. Up to date, information on long COVID-19 among Jordanian patients has not been reported. Therefore, we sought to conduct this cross-sectional study utilizing a self-administered survey. The survey asks a series of questions regarding participant demographics, long COVID-19 symptoms, information about pre-existing medical history, supplements, vaccination history, and symptoms recorded after vaccination.  Chi square analysis was conducted on 990 responders, and the results showed a significant correlation (P<0.05) between ..., , , # Long COVID-19 in Jordan

The data represent responses to a self-reporting questionnaire that was designed to address long COVID-19 status and factors that may associate with it among Jordanians. It included questions regarding COVID-19 symptoms, pre-existing medical history, treatment and supplements, COVID-19 vaccination history, and symptoms recorded after vaccination. We adopted the definition of long COVID-19 that refers to individuals experiencing at least one symptom longer than four weeks.

## Description of the data and file structure

The data were entered into SPSS data file and organized as follows: Demographic data (columns B-H) are sex (Male:0, Female: 1), age (18-34:2, 35-44:3, 45-54:4, >55: 5), marital status (single:1, married:2, other:3), smoking (No:0, Yes:1), employment status (not:0, goverment:1, private:2), and obesity (non- obese:0, obese:1), hospitalization required (column I, No:0, Yes:1), number of times of infected with COVID-19 (column J, 1,2,3 times), ...